a proactive syndicate player —
investment in high-potential companies
Over the years, GLSV has established a sound track record through discerning investments in high-potential companies. After registration of the original fund in 1996, the available capital of Euro 66 million has been invested in first and follow-on financing rounds of 18 ventures active in the life sciences.
The positive development of the first fund has been highlighted by successful exits and merger & acquisition transactions. The second fund is being used to finance further promising companies that operate in significant markets with considerable upside potential.
The latest news on our investments from both funds is available in our our News & Events section.